Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial.

J Bagel; W T Garland; D Breneman; M Holick; T W Littlejohn; D Crosby; H Faust; D Fivenson; J Nichols

doi:10.1016/s0190-9622(98)70590-0

Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial.

Identifier:nobleid.org/w1/20260515/BBCCEF72

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BBCCEF72.svg?ark=w1%2F20260515%2FBBCCEF72)](https://nobleid.org/work/w1/20260515/BBCCEF72)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Administration of DAB389IL-2 to patients with recalcitrant psoriasis: a double-blind, phase II multicenter trial.

Identifier:nobleid.org/w1/20260515/BBCCEF72

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/BBCCEF72.svg?ark=w1%2F20260515%2FBBCCEF72)](https://nobleid.org/work/w1/20260515/BBCCEF72)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work